CTI BIOPHARMA CORP (26) | Termination Agreements (2)
- Amendment No 1. to the Asset Return and Termination Agreement, by and between Baxalta Incorporated and CTI BioPharma Corp., dated as of May 31, 2022 (Filed With SEC on August 8, 2022)
- Termination and Transfer Agreement, dated as of February 25, 2019, by and among on the one hand, CTI BioPharma Corp. and CTI Life Sciences Limited, and, on the other hand, Les... (Filed With SEC on February 27, 2019)
